(16384177), T. P. D., (16384180), K. W. E., (15107821), M. G. R., (16384183), M. Z., (16384186), Y. Q. R., (16384189), X. Z., . . . (10258780), F. M. (2025). Figure S1, Figure S2, Figure S3, Figure S4, Figure S5 from Adavosertib Enhances Antitumor Activity of Trastuzumab Deruxtecan in HER2-Expressing Cancers.
Citación estilo Chicago(16384177), Timothy P. DiPeri, et al. Figure S1, Figure S2, Figure S3, Figure S4, Figure S5 from Adavosertib Enhances Antitumor Activity of Trastuzumab Deruxtecan in HER2-Expressing Cancers. 2025.
Cita MLA(16384177), Timothy P. DiPeri, et al. Figure S1, Figure S2, Figure S3, Figure S4, Figure S5 from Adavosertib Enhances Antitumor Activity of Trastuzumab Deruxtecan in HER2-Expressing Cancers. 2025.
Warning: These citations may not always be 100% accurate.